These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11121993)

  • 21. Serum prostate-specific antigen and the biologic progression of prostate cancer.
    Kabalin JN; McNeal JE; Johnstone IM; Stamey TA
    Urology; 1995 Jul; 46(1):65-70. PubMed ID: 7541589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma.
    Gettman MT; Pacelli A; Slezak J; Bergstralh EJ; Blute M; Zincke H; Bostwick DG
    Urology; 1999 Sep; 54(3):479-85. PubMed ID: 10475358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histopathological findings in extended prostate biopsy with PSA < or = 4 ng/mL.
    Leite KR; Srougi M; Dall'Oglio MF; Sanudo A; Camara-Lopes LH
    Int Braz J Urol; 2008; 34(3):283-90; discussion 290-2. PubMed ID: 18601758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of prostate-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a large referral practice.
    Amling CL; Blute ML; Lerner SE; Bergstralh EJ; Bostwick DG; Zincke H
    Mayo Clin Proc; 1998 May; 73(5):401-6. PubMed ID: 9581578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of stage migration and practice changes on high-risk prostate cancer: results from patients treated with radical prostatectomy over the last two decades.
    Fossati N; Passoni NM; Moschini M; Gandaglia G; Larcher A; Freschi M; Guazzoni G; Sjoberg DD; Vickers AJ; Montorsi F; Briganti A
    BJU Int; 2016 May; 117(5):740-7. PubMed ID: 25787671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of prostate-specific antigen in stage T1c prostate cancer treated by radical prostatectomy.
    Cookson MS; Fleshner NE; Soloway SM; Fair WR
    Urology; 1997 Jun; 49(6):887-93. PubMed ID: 9187696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and Gleason score to predict positive surgical margins.
    Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
    Urology; 2004 Sep; 64(3):516-21. PubMed ID: 15351582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of outcome after radical prostatectomy in men with organ-confined Gleason score 8 to 10 adenocarcinoma.
    Rioux-Leclercq NC; Chan DY; Epstein JI
    Urology; 2002 Oct; 60(4):666-9. PubMed ID: 12385930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era.
    Tosoian JJ; Chappidi M; Feng Z; Humphreys EB; Han M; Pavlovich CP; Epstein JI; Partin AW; Trock BJ
    BJU Int; 2017 May; 119(5):676-683. PubMed ID: 27367645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of clinically nonpalpable prostate-specific antigen-detected (cT1c) versus palpable (cT2) prostate cancers in patients undergoing radical retropubic prostatectomy.
    Ghavamian R; Blute ML; Bergstralh EJ; Slezak J; Zincke H
    Urology; 1999 Jul; 54(1):105-10. PubMed ID: 10414735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Migration of pathological stage after radical prostatectomy to higher risk tumors of relapse: comparative two-center study between 2005 and 2010].
    Beauval JB; Roumiguié M; Doumerc N; Thoulouzan M; Huyghe E; Allory Y; Mazerolles C; de la Taille A; Malavaud B; Rischmann P; Soulié M; Salomon L
    Prog Urol; 2012 Dec; 22(16):1015-20. PubMed ID: 23178098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stratification of pathologic features in radical prostatectomy specimens that are predictive of elevated initial postoperative serum prostate-specific antigen levels.
    Humphrey PA; Frazier HA; Vollmer RT; Paulson DF
    Cancer; 1993 Mar; 71(5):1821-7. PubMed ID: 7680602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
    Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
    J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterizing prostatic adenocarcinomas in men with a serum prostate specific antigen level of < 4.0 ng/mL.
    Sokoloff MH; Yang XJ; Fumo M; Mhoon D; Brendler CB
    BJU Int; 2004 Mar; 93(4):499-502. PubMed ID: 15008717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in prostate cancer at radical prostatectomy during the prostate specific antigen era: an Italian experience.
    Bollito E; Terrone C; Volpe A; Porpiglia F; Cracco C; Poggio M; Grande S; Righi L; Bellina M; Papotti M; Scarpa RM
    Anal Quant Cytol Histol; 2008 Jun; 30(3):152-9. PubMed ID: 18630840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of potentially insignificant prostate cancer in men undergoing radical prostatectomy for clinically organ-confined disease.
    Miyake H; Sakai I; Harada K; Hara I; Eto H
    Int J Urol; 2005 Mar; 12(3):270-4. PubMed ID: 15828954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing PSA outcome after radical prostatectomy or magnetic resonance imaging-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate.
    D'amico AV; Tempany CM; Schultz D; Cormack RA; Hurwitz M; Beard C; Albert M; Kooy H; Jolesz F; Richie JP
    Urology; 2003 Dec; 62(6):1063-7. PubMed ID: 14665356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive value of primary Gleason pattern 4 in patients with Gleason score 7 tumours treated with radical prostatectomy.
    Khoddami SM; Shariat SF; Lotan Y; Saboorian H; McConnell JD; Sagalowsky AI; Roehrborn CG; Koeneman KS
    BJU Int; 2004 Jul; 94(1):42-6. PubMed ID: 15217428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes in patients with Gleason score 8-10 prostate cancer: relation to preoperative PSA level.
    McGuire BB; Helfand BT; Loeb S; Hu Q; O'Brien D; Cooper P; Yang X; Catalona WJ
    BJU Int; 2012 Jun; 109(12):1764-9. PubMed ID: 22017732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
    Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
    BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.